Examkin

Question

Difficulty: HardPelvic Floor Disorders and Urogynecology

During a routine follow-up appointment, a 68-year-old female reports a recent onset of bothersome urinary leakage. Over the past month, she has experienced frequent episodes where a sudden, intense desire to pass urine is immediately followed by incontinence. Additionally, she reports an increase in nighttime awakenings to void. Her past medical history includes poorly controlled type 2 diabetes mellitus, essential hypertension, and painful peripheral neuropathy. Medication adjustments one month ago included the addition of amitriptyline. Current vital signs are within normal limits. On physical examination, there is mild suprapubic fullness but no identifiable anterior or posterior vaginal wall defects. The Q-tip test demonstrates a maximum straining angle of 15∘15^\circ from the horizontal. Bedside bladder ultrasonography demonstrates a residual volume of 410 mL immediately after the patient voluntarily voids. Dipstick urinalysis shows no abnormalities. Which of the following is the most appropriate next step in the care of this patient?

  1. Discontinuation of the tricyclic antidepressantAnswer
  2. B
    Prescription of a daily antimuscarinic medication
  3. C
    Administration of empiric oral fluoroquinolone therapy
  4. D
    Surgical placement of a tension-free vaginal tape
  5. E
    Performance of an outpatient endometrial biopsy

Answer

Discontinuation of the tricyclic antidepressant
The correct answer identifies that the patient is suffering from overflow incontinence secondary to detrusor underactivity. Although she describes symptoms mimicking urgency urinary incontinence (sudden desire to pass urine), the objective finding of a post-void residual (PVR) volume of 410 mL indicates severe urinary retention. Normal PVR is typically less than 50 to 100 mL. This retention is highly likely an adverse effect of her recently prescribed amitriptyline, a tricyclic antidepressant with strong anticholinergic properties that block parasympathetic input to the detrusor muscle, thereby preventing adequate bladder contraction. The most appropriate initial step in management is to discontinue the offending medication.

Step-by-Step Solution

1
Analyze the patient's presenting symptoms and objective data.
The patient reports urgency and frequency, but objective testing reveals a post-void residual (PVR) of 410 mL and a normal Q-tip test.
Subjective symptoms of urgency can occur in multiple incontinence subtypes; integrating objective data like PVR and urethral mobility is necessary to differentiate the exact etiology.
2
Identify the primary mechanism of incontinence.
A PVR greater than 150-200 mL confirms urinary retention with overflow incontinence, rather than pure urgency incontinence (which typically has a normal PVR).
When the bladder becomes overdistended, small amounts of urine frequently leak out, and the patient may feel a constant or sudden urge to void despite an inability to empty.
3
Determine the underlying etiology based on the patient's history.
The patient recently started amitriptyline for diabetic neuropathy, a medication with potent anticholinergic side effects.
Anticholinergic medications inhibit parasympathetic stimulation of the detrusor muscle, impairing bladder contraction and leading to acute urinary retention, especially in patients with underlying risks like diabetic cystopathy.
4
Select the most appropriate management.
Cessation of the recently started amitriptyline.
The primary intervention for iatrogenic overflow incontinence is discontinuing the offending pharmacologic agent.

Key Concept

Overflow incontinence can paradoxically present with urgency and frequency symptoms; diagnosis requires identifying an elevated post-void residual volume, and initial management involves stopping offending anticholinergic medications.
Rate this question

Topics

Pelvic Floor Disorders and Urogynecology

More questions from this topic